Tpsu controlled substance management system

Active Awarded Last action

Contract number
75H70724F80015
Awardee
Awarding agency
Obligated
$89,304

Award facts

Opportunity
  • 75H70723Q00110 Solicitation number
Contract value 91% obligated
  • $89,304.44 Current, with exercised options
  • $98,227.63 Potential, with all options
Completion date 60% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Taos, NM 87571, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 · MOD P4 - exercise OY #3 for tpsu $8,418
Funding Only Action P00003 · MOD P3 - add funding to line item #1 to pay on open invoices. $8,392
Exercise an Option P00002 · MOD P2 - exercise OY 2 $7,942
Exercise an Option P00001 · MOD P1 - exercise OY 1 $7,492
Original award $57,060

About this award

Omnicell, Inc. has been awarded a delivery order valued at $98,227.63 under Modification P4 for Exercise Option Year 3 of the TPSU Controlled Substance Management System contract. The delivery order, issued on February 20, 2024, with an ultimate completion date of July 31, 2028, will be performed in Taos, New Mexico and funded by the Indian Health Service. The award utilizes a firm fixed price structure with no set-aside designation, leveraging Omnicell's established position as a leading provider of pharmacy automation and medication management solutions to federal healthcare agencies. The delivery order falls under the parent Medical Equipment and Supplies GSA Schedule (FSS-65-II-A), which provides the contractual framework for procurement of automated dispensing systems and related pharmacy technology services.

As a for-profit organization headquartered in Pennsylvania, Omnicell brings extensive federal contracting experience to this Indian Health Service procurement, with a portfolio exceeding $100 million in aggregate federal contract value. The company specializes in developing controlled substance management systems, automated dispensing cabinets, medication carousels, and comprehensive maintenance and support services across federal healthcare networks. This delivery order represents the continuation of Omnicell's ongoing support for the Indian Health Service's medication management infrastructure, consistent with the company's established role as a primary vendor for federal healthcare entities including the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health Clinical Center.

Quick answers

Who was awarded contract 75H70724F80015?

75H70724F80015 was awarded to Omnicell, Inc. by Indian Health Service (Department of Health and Human Services) on February 20, 2024.

How much is contract 75H70724F80015 worth?

The government has obligated $89,304 on 75H70724F80015. Its potential value, with all options, is $98,228.

Is contract 75H70724F80015 an order under another contract?

Yes. 75H70724F80015 is a delivery order under 36F79723D0073, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).

Was contract 75H70724F80015 competed?

The extent of competition for 75H70724F80015 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award